Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial.

Yonsei Med J · 2019 · PMC6342711 · PMID 30666834

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp <0.001actually significant

Intriguingly, in EBV-positive patients, the difference in DFS between SPC-prognosis groups was highly significant [HR: 2.608 (0.735–9.254) in intermediate-risk, 17.656 (3.839–81.200) in high-risk group, log-rank p <0.001], necessitating further investigation.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.